Robots, Runways, and Run Rates- Innovation Wave Drives Pre-Market Tone

November 28, 2025

DENVER, Colo., Nov 28, 2025 (247marketnews.com)- A busy news cycle is setting the tone for the trading day as robotics, medical technology, biotech, and next-generation materials companies step into the spotlight.

Microbot Medical (NASDAQ:MBOT) Breaks New Ground as Emory Becomes First LIBERTY® Adopter

Microbot Medical is commanding early attention after announcing that Emory University Hospital has become the first hospital in the world to adopt its LIBERTY® Endovascular Robotic System for patient care.

LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, positioned to reduce radiation exposure and physical strain while enabling precise vascular navigation.

Just weeks after commencing its limited market release, Microbot is preparing for a full commercial roll-out at the SIR Conference in April 2026, a key milestone that could accelerate adoption.

Emory’s Division Director for Interventional Radiology, Dr. J. David Prologo, said the introduction of technologies like LIBERTY aligns with the hospital’s commitment to remain “at the forefront of technological advancement,” particularly given its strengths in endovascular and oncology services.

CEO Harel Gadot called the moment “extraordinary,” noting that the first adoption of a single-use robotic system marks a milestone not only for the company but for the broader robotic-surgery landscape.

MBOT becomes one of today’s major innovation-driven tickers to watch into the open.

HeartBeam (NASDAQ:BEAT) Engages FDA After NSE Letter, as Company Pursues Multiple Regulatory Paths

HeartBeam is in focus after providing an update on the regulatory path for its 12-lead ECG Synthesis Software, following receipt of a Not Substantially Equivalent (NSE) determination on its 510(k) submission.

Key developments shaping sentiment:

  • The FDA has signaled willingness to work toward a constructive resolution.
  • The company’s clinical study (VALID-ECG) met its endpoints, reinforcing confidence in the underlying data.
  • HeartBeam believes FDA concerns can be addressed through labeling modifications.
  • The company will pursue multiple parallel pathways, including appeal and 510(k) resubmission options.
  • An appeal process would typically resolve within ~60 days of submission.

CEO Robert Eno noted that HeartBeam has had “extremely positive interactions” with the FDA over two years and believes that the remaining questions can be “readily addressed.”

BEAT will be on watch today for sentiment swings as the market digests the company’s multi-track regulatory strategy.

Kraig Biocraft Laboratories (OTCQB:KBLB) Extends Hiring Wave as Spider Silk Production Scales

KBLB is attracting early speculative interest as the company pushes forward with a major hiring expansion across Southeast Asia to support rising production throughput and a new facility under development.

Recruits will train under Dr. Nirmal Kumar, a top sericulture expert, signaling accelerated preparation for industrial-scale spider silk manufacturing.

With facility build-outs ongoing, the market is closely watching for evidence of production milestones heading into 2026.

Pasithea Therapeutics (NASDAQ:KTTA) Prices $60M Offering Backed by Major Healthcare Funds

Pasithea Therapeutics priced a $60 million public offering at $0.75 per share, extending the company’s cash runway through at least H1 2028.

The raise was led by a consortium of major healthcare investors, including:

  • Vivo Capital
  • Janus Henderson Investors
  • Coastlands Capital
  • Columbia Threadneedle Investments
  • Adage Capital Partners
  • Squadron Capital Management

Net proceeds will be used for clinical development of PAS-004, emerging technologies, licensing opportunities, and potential acquisitions.

With H.C. Wainwright as exclusive placement agent and closing expected by December 1, KTTA is set to be one of today’s heavier-volume biotech movers.

TMC the metals company (NASDAQ:TMC) and Aditxt (NASDAQ:ADTX) Carry Strength Into the Holiday Stretch

TMC and ADTX continue to push momentum from last week into the quiet holiday trading window.

  • TMC remains supported by investor focus on critical mineral supply chains and its deep-sea resource strategy.
  • ADTX is riding renewed interest following recent restructuring and strategic updates.

Both appear poised for above-average retail flow as the market reopens.

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com

Please click here to read the full Kraig Labs analyst report on 247marketnews.com.

For more information, please visit: www.kraiglabs.com

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated for providing ongoing KBLB market outreach and other services. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, KTTA, TMC, ADTX, MBOT, BEAT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.